An Open Label Study to Evaluate the Effect of Avastin in Association With Chemotherapy on Progression-free Survival in Patients With Progressive Advanced/Metastatic Well-differentiated Digestive Endocrine Tumors of the Gastrointestinal Tract
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Median progression-free survival
Event driven
No
Clinical Trials
Study Director
Hoffmann-La Roche
France: AFSSAPS (Agence francaise de securite sanitaire des produits de sante)
ML20383
NCT00448136
July 2007
November 2011
Name | Location |
---|